UF Health Cancer Center researchers will present a wide range of innovative cancer research at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 30 to June 3 in Chicago.
The ASCO Annual Meeting is one of the most significant gathering of oncology professionals worldwide, allowing attendees to make connections and forging collaborations that can change the landscape of cancer care.
The meeting features state-of-the-art research, groundbreaking treatments and visionary insights. This year’s program features over 200 sessions and state-of-the-art science.
UF Health Cancer Center members and UF faculty appear in bold below and trainees in italics.
Oral Abstracts
Session Title: Pediatric Oncology 1
May 31 | 3 – 6 p.m.
A phase 2 randomized study of chemoimmunotherapy with or without eflornithine (DFMO) in relapsed/refractory neuroblastoma: A Children’s Oncology Group (COG) report
Margaret Macy, Arlene Naranjo, Fan Zhang, Michael Acord, Thomas Cash, Steven DuBois, Jennie Foster, Kristin Knight, Michael Hogarty, Rajen Mody, Daniel Morgenstern, Marguerite Parisi, Navin Pinto, C. Reynolds, Michelle Keyel, Barry Shulkin, David Ziegler, Rochelle Bagatell, Julie Park, Kelly Goldsmith
Session Title: Pediatric Oncology II
June 2 | 8 – 11 a.m.
Longitudinal change in cardiac function after doxorubicin and dexrazoxane: A report from COG ALTE11C2
Erin Mobley, David Doody, Steven Colan, Sanjeev Aggarwal, Richard Aplenc, Saro Armenian, K. Baker, Smita Bhatia, Louis Constine, David Freyer, Lisa Kopp, Wendy Leisenring, Nao Sasaki, Lynda Vrooman, Barbara Asselin, Cindy Schwartz, Eric Chow, Steven Lipshultz
Session Title: Prevention, Risk Reduction, and Genetics
June 2 | 11:30 a.m. – 2:30 p.m.
Association of glucagon-like peptide 1 receptor agonists with cancer risk in obesity adults with and without diabetes: A target trial emulation study.
Hao Dai, Yao An Lee, Ying Lu, Thomas George, Jingchuan Guo, Jiang Bian
Rapid Oral Abstract
Session Title: Genitourinary Cancer — Kidney and Bladder
May 31 | 1:15 – 2:45 p.m.
Zanzalintinib (zanza) + nivolumab (nivo) ± relatlimab (rela) in patients (pts) with previously untreated clear cell renal cell carcinoma (ccRCC): Results from an expansion cohort of the phase 1b STELLAR-002 study
Jad Chahoud, Bradley McGregor, Oscar Reig Torras, Pedro Barata, Jonathan Chatzkel, Simon Fu, Daniel Castellano, Pablo Maroto-Rey, Julia Martinez Perez, Philippe Barthelemy, Joanna Wojcik-Tomaszewska, Benjamin Garmezy, Marta González Cordero, Mohan Liu, Xinyu Wang, John Russell, Lana Andrianova, Neil Shah
Session Title: Developmental Therapeutics — Immunotherapy
June 1 | 11:15 a.m. – 12:45 p.m.
Durable responses in ICI-refractory or acquired resistance: Phase 2 study of NP-G2-044 combined with anti-PD-1 therapy
Anup Kasi, Michael Birrer, Jason Brown, Sanjay Chandrasekaran, Vincent Chung, Richard Frank, Shirish Gadgeel, Thomas George, Shadia Jalal, Alberto Mendivil, Andrew Poklepovic, Jennifer Segar, Alexander Spira, Janos Tanyi, Hira Yousaf, Jillian Zhang, Xin-Yun Huang, Jose Jimeno, Frank Tsai
Session Title: Pediatric Oncology
June 2 | 3 – 4:30 p.m.
Second malignant neoplasm risk after mediastinal radiotherapy for pediatric Hodgkin lymphoma on Children’s Oncology Group AHOD1331
Sarah Milgrom, Harald Paganetti, Hitesh Dama, Lindsay Renfro, Yue Wu, Isaac Meyer, Susan Parsons, Angela Punnett, Anne-Marie Charpentier, Andrea Lo, Raymond Mailhot Vega, Frank Keller, Kara Kelly, Bradford Hoppe, Sharon Castellino, David Hodgson
Integrated molecular characterization of pediatric soft tissue sarcomas: A report from the COG and CCDI molecular characterization initiative
Sapna Oberoi, Julia Meade, Erin Rudzinski, Avery Funkhouser, Catherine Cottrell, Douglas Hawkins, Javed Khan, Elaine Mardis, Nilsa Ramirez, Theodore Laetsch, Wei Xue, Malcolm Smith, Frederic Barr, Corinne Linardic, Subhashini Jagu, Aaron Weiss, Rajkumar Venkatramani, Gregory Reaman, John Shern
Session Title: Medical Education and Professional Development
June 2 | 9:45 – 11:15 a.m.
Research productivity of international medical graduate (IMG) hematology and oncology fellows in the United States (US)
Arya Mariam Roy, Tarrant McPherson, Chalothorn Wannaphut, Divine Besong Arrey Agbor, Sadia Ansar, Oluwaseun Adeleke, Avi Harisingani, Jesus Flores Banda, Gauri Pikale, Safa Afridi, Rafik ElBeblawy, Changchuan Jiang, Karun Neupane, Taofeek Owonikoko, Mariana Chavez Mac Gregor, Martina Murphy, Nazli Dizman, Ziad Bakouny, Fatemeh Ardeshir Larijani, Toni Choueiri
Clinical Science Symposium
Session Title: The Future Is Now: Innovations in Medical Education
May 31 | 1:15 – 2:45 p.m.
Integration of a podcast curriculum (PC) to improve hematology oncology fellow (HOF) knowledge: A multi-center cluster randomized control trial.
Vivek Patel, Karine Tawagi, Samantha A. Armstrong, Daniel Hausrath, Inas Abuali, Sean M. Taasan, Ankoor Biswas, Jonathan L. Berry, Srijan Valasapalli, Kyle Kidwell, Agrima Mian, Shivang Danak, Moriah Forster, Jessica M. Stempel, Pranali S. Pachika, Maya Abdallah, Sheila DeYoung, Lauren Mendelson, Megan E. Melody, Ronak Mistry
Poster Sessions
May 31 | 9 a.m. – noon
Alliance A022101/NRG-GI009: A pragmatic randomized phase III trial evaluating total ablative therapy for patients with limited metastatic colorectal cancer—Evaluating radiation, ablation, and surgery (ERASur)
Eric Miller, Kathryn Hitchcock, Qian Shi, Jesse Dixon, Sepideh Gholami, Sarah White, Christina Wu, Christopher Goulet, Kyung-Wook Jee, Chadwick Wright, Rona Yaeger, Ardaman Shergill, Theodore Hong, Thomas George, Eileen O’Reilly, Jeffrey Meyerhardt, Paul Romesser
Colon adjuvant chemotherapy based on evaluation of residual disease (CIRCULATE-NORTH AMERICA): NRG-GI008
Arvind Dasari, Guan Yu, Scott Kopetz, Shannon Puhalla, Peter Lucas, Ibrahim Halil Sahin, Dustin Deming, Philip Philip, Theodore Hong, Yesenia Rojas-Khalil, Jonathan Loree, Norman Wolmark, Greg Yothers, Thomas George, Christopher Lieu
Trials in progress: Alliance A022104/NRG-GI010—A randomized phase II/III trial testing the efficacy of triplet versus doublet chemotherapy regarding clinical complete response and disease-free survival in patients with locally advanced rectal cancer (LARC; the Janus Rectal Cancer trial)
Caleah Kitchens, Qian Shi, Arvind Dasari, Julio Garcia-Aguilar, Hanna Sanoff, Thomas George, Theodore Hong, Greg Yothers, Philip Philip, Tareq Al Baghdadi, Olatunji Alese, Aron Bercz, Manju George, Eileen O’Reilly, Jeffrey Meyerhardt, Ardaman Shergill, Natally Horvat, Paul Romesser, William Hall, Jesse Joshua Smith
Growth recovery in patients with BRAF altered pediatric low-grade gliomas (LGG) after discontinuation of tovorafenib
Cassie Kline, Karen Wright, Lindsay Kilburn, Susan Chi, Daniel Landi, Jasper van der Lugt, Sarah Leary, Mohamed Abdelbaki, Simon Bailey, Karsten Nysom, Dong-Anh Khuong-Quang, Elias Sayour, Olaf Witt, Pablo Hernáiz Driever, Valérie Larouche, Ashley Bailey-Torres, Lindsey Ott, Jiaheng Qiu, Lisa McLeod, Sabine Mueller
Factors associated with survival following relapse of high-risk neuroblastoma: A study from the International Neuroblastoma Risk Group (INRG) Data Commons.
Daniel Morgenstern, Pei-Chi Kao, Lucas Moreno, Jordan Staunton, Rochelle Bagatell, Pablo Berlanga, Ulrike Poetschger, Arlene Naranjo, Fan Zhang, Miho Kato, Miki Ohira, Andrew Pearson, Susan Cohn, Wendy London
A multicenter, pivotal trial of microbubble-enhanced transcranial focused ultrasound (MB-FUS) for plasma-based liquid biopsy in patients with glioblastoma (LIBERATE)
Manmeet Ahluwalia, Ahmad Ozair, Terence Burns, Michael McDermott, Alon Mogilner, Bhavya Shah, Toral Patel, Jordina Rincon-Torroella, Mark Mishra, Richard Everson, Justin Hilliard, Yarema Bezchlibnyk, Matthew Hibert, Julia Zhu, Jeffrey Weinberg, Christopher Cifarelli, Ali Rezai, Vibhor Krishna, Nir Lipsman, Graeme Woodworth
May 31 | 1:30 – 4:30 p.m.
Evaluating the impact of long-term glucocorticoid use on cancer risk in patients with rheumatologic diseases: A retrospective cohort study.
Farigol Hakem Zadeh, Nikita Shah, Juan Varela, Victoria Bird
How cancer impacts adolescents’ and young adults’ (AYAs) scholastic experiences: Insight on supportive survivorship care needs from AYAs, parents, and clinicians
Carla Fisher, Kelsey Lunsford, Emma Bryan, Diliara Bagautdinova, Raymond Mailhot Vega, Maria Sae-Hau, Elisa Weiss, Joanne Lagmay, Carma Bylund
Sex-based disparities in HPV-related cancer outcomes: Insights into social determinants of health
Xiangren Wang, Yenan Zhu
Trends in early-onset gastrointestinal cancers: A comprehensive analysis of US cancer statistics (2001–2021)
Abdul Qahar Yasinzai, Sebawe Syaj, Ibrahim Halil Sahin, Ibrahim Nassour, Thomas George, Anwaar Saeed
Efficacy of low-dose nivolumab combined with chemotherapy as neoadjuvant treatment for lung cancer
Aline Fares, Joao Soler, Isaac Rodrigues, Eduardo Constantino, Thais Fares, Bruno Uchôa Jr., Maira Abreu, Henrique Nietmann, Luciana Vargas, Adriana Joaquim, Celso Murilo Nálio Matias de Faria, Daniel Araujo
Analyzing trends in multimorbidity-related mortality among patients with cancer and myocardial infarction: A decadal analysis
Abdul Ahad, Shree Rath, Muzamil Khan, Asad Ali Ahmed Cheema, Fareeda Brohi, Muhammad Riyyan, Nouman Aziz, Waseem Nabi, Adnan Bhat, Mir Shahnawa
June 1 | 9 a.m. – noon
Gotistobart in combination with pembrolizumab in patients with advanced melanoma who have progressed on PD-1 inhibitors with or without CTLA-4 inhibitors
Siwen Hu-Lieskovan, Kari Kendra, Kai He, Bently Doonan, Eric Schaefer, Edward Arrowsmith, Ki Chung, Eric Whitman, Ulka Vaishampayan, Svetlana Shpyro, Qiong Wang, Juanjuan Su, Chris Leung, Kazuharu Kai, Yang Liu, Pan Zheng, Tianhong Li
Nautilus, a phase 1b/2 trial of combining oral HDAC inhibitor (HDACi) with MEK inhibitor (MEKi) in patients with NRAS-mutated metastatic melanoma (MM)
Rodabe Amaria, Herbert Duvivier, Katy Tsai, Parisa Momtaz, Robert Galamaga, Evan Pisick, Bently Doonan, Amy Weise, Natalie Langr, James Winkler, Harish Dave, Jennifer Diamond, Ryan Sullivan
Longitudinal ctDNA monitoring for post-surgical molecular residual disease in patients with stage I-IIIb melanoma.
George Ansstas, Karam Khaddour, Sumedha Sudhaman, Karen Lin, Griffin Budde, Andrew Poklepovic, Bently Doonan, Meghan Mooradian, Ryan Sullivan, Vincent Ma, Jeremy Rosiecki, Steven Liu, Ronald Drengler, Daniel Flora, Georgia Beasley, Kristen Rhodin, John Hyngstrom, Elise Brunsgaard, Minetta Liu, Alan Tan
Progression-free survival (PFS) assessment by blinded independent central review (BICR) versus local investigator (LI) in metastatic melanoma (MM) randomized controlled trials (RCT): A systematic review and meta-analysis
Islam Eljilany, Eissa Jafari, Abdullah Alhumaid, Zeynep Eroglu, Joseph Markowitz, Lilit Karapetyan, Andrew Brohl, Nikhil Khushalani, Patrick Hwu, Ahmad Tarhini
June 2 | 9 a.m. – noon
Enhancing precision oncology for Haitian breast cancer patients through deep learning-enabled computational pathology tools
Rebecca Henderson, Dagoberto Pulido-Arias, Joraly Lormil, Christophe Millien, Marie Djenane Jose, Gabriel Flambert, Jean Bontemps, Emmanuel Georges, Tiago Gonçalves, Elizabeth Gerstner, Jayashree Kalpathy-Cramer, Ali Brown, Kenneth Landgraf, Christopher Bridge, Dan Milner, Azin Mashayekhi, Jane Brock, Albert Kim
Global trends and regional disparities in young-onset breast cancer: Age-specific patterns from 1990 to 2021
Muzamil Khan, Waseem Nabi, Nouman Aziz, Shree Rath, Reem Eisa, Munaza Afaq, Adnan Bhat, Mir Shahnawaz, Maryam Inam Zaroo
June 2 | 1:30 – 4:30 p.m.
Implementation of clinical trial communication skills training for oncology fellows.
Carma Bylund, Naomi Parker, Lauren Lavender, Tithi Amin, Susan Eggly, Daphne Friedman, Martina Murphy, Maria Sae-Hau, Andrea Sitlinger, Stephanie Staras, Leah Szumita, Jonathan Thomas, Danny Trotier, Elisa Weiss
Pertuzumab plus trastuzumab (P+T) in patients (pts) with bladder (BC) and ovarian cancer (OC) with ERBB2/3 alterations (alt): Results from the Targeted Agent and Profiling Utilization Registry (TAPUR) study
John Chan, Michael Rothe, Pam Mangat, Elizabeth Garrett-Mayer, Evan Pisick, Pooja Ghatalia, Andrew Gregory, Mollie deShazo, Kathryn Mileham, Martina Murphy, Olatunji Alese, Elie Dib, Peter Kohler, Justin Moyers, Abby Gregory, Dominique Hinshaw, Gina Grantham, Susan Halabi, Richard Schilsky
A phase 2 study of olaparib in IDH1 and IDH2 mutant advanced chondrosarcomas and other solid tumors
Philippos Costa, Mary Josephine Pilat, Jordi Rodon Ahnert, Melissa Burgess, Gabriel Tinoco, Julia Close, Roman Groisberg, Vivek Subbiah, Benjamin Powers, Candace Haddox, Juneko Grilley-Olson, Vicki Keedy, Jing Li, S. Ivy, Abhijit Patel, Geoffrey Shapiro, Jeffrey Ishizuka, Kurt Schalper, Patricia LoRusso
Publication Only
Murine metastatic embryonal rhabdomyosarcoma survival and immune response with a total tumor RNA lipid particle aggregate vaccine.
Leighton Elliott, Andrece Powell, Madison Sowers, Lauren Lavender, Darrice Montgomery, Nicolas Hincapie, Dhruv Soni, Dingpeng Zhang, Hector Mendez-Gomez, Elias Sayour
Impact of year-end holidays on delayed cancer diagnoses and survival implications: A population-based study
Abdul Qahar Yasinzai, Paul Crispen, Devika Das, Stephanie Staras, Padraic O’Malley, Ibrahim Nassour, Kathryn Hitchcock, Ramzi Salloum, Yi Guo, Thomas George
Clinical large language model to predict loss to follow up for oncology patients discharged to skilled nursing facilities
Tianshi Liu, Ziyi Chen, Yonghui Wu, Jonathan Chatzkel, Yi Guo, Jiang Bian
Using a patient registry and novel follow-up protocol to impact identification, treatment, and adherence rates in HR+, HER2- early breast cancer patients at UF Health
Kadrin Wilfong, Karen Daily, Eric Rosenberg, Rachel Reise, Sumaya Abuloha, Julia Yang, Chris Kriz
Dabrafenib and trametinib vs anti-PD(L)1 for the adjuvant treatment of locally advanced BRAF-mutant melanoma: A systematic review and meta-analysis
Daniel Araujo, Bruno Lins de Souza, Mariana Fauth Seibel, Aline Fares, Vitor Liutti
PROMIS scores of cancer survivors in the Comprehensive Outcomes for After Cancer Health (COACH) study: An interim analysis
Marilyn Hammer, Hajime Uno, Barbara Halpenny, Alexi Wright, Elizabeth Arthur, Kristen Fessele, Anneliese Gonzalez, Michael Harrison, Hilda Haynes, Abbey Kaler, Jessica Krok-Schoen, Robin Lally, Jennifer Loftis, Debra Lyon, Kathrin Milbury, Leorey Saligan, Rachael Schmidt, Maria Swartz, Meagan Whisenant, Kelly Brassil
Neoadjuvant dose-dense anthracycline and cyclophosphamide in combination with carboplatin, paclitaxel, and pembrolizumab for triple-negative breast cancer: A systematic review and meta-analysis
Vitor Liutti, David Vale, Bruno Lins de Souza, Mariana Fauth Seibel, Rafael Manea, Daniel Araujo
Safety and efficacy of subcutaneous versus intravenous administration of PD (L)1 inhibitors in patients with solid tumors: A systematic review and meta-analysis
Carlotta Persaud, José Reinaldo De Oliveira Junior, Pedro Reis, Luisa Araujo, João Pedro Oliveira, Mariana Noronha, Bruno Murad Carvalho, Daniel Araujo
Recurrence rates after anti-PD1 discontinuation for advanced melanoma: A systematic review and single-arm meta-analysis.
Bruno Lins de Souza, Mariana Fauth Seibel, Amanda Ribeiro Rangel, João Netto, Bernardo Gabriele Collaço, Gabriel Chagas, Vitor Liutti, Maysa Vilbert, Daniel Araujo
Survival analysis of metastatic Merkel cell carcinoma patients pre- and post-immunotherapy era in the US: A retrospective population-based study
Marjan Khan, Hannah Chaudhury, Agha Wali, Abdul Yasinzai, Asif Iqbal, Hritvik Jain, Luis Brandi, Nabin Karki, Asad Ullah
Toxicity profile of fruquintinib (Fruq) versus regorafenib (Rego) in refractory metastatic colorectal cancer (mCRC)
Yazan Hamadneh, Sebawe Syaj, Pooya Jalali, Abdul Qahar Yasinzai, Ibrahim Halil Sahin, Anwaar Saeed
Perioperative chemotherapy versus preoperative chemoradiotherapy in resectable esophageal cancer: A real-world analysis.
Sebawe Syaj, Leen Alkuttob, Abdul Yasinzai, Arjun Pennathur, Evan Alicuben, Joel Greenberger, Susannah Ellsworth, Neal Mccall, James Luketich, Ibrahim Halil Sahin, Anwaar Saeed
Demographic and clinical disparities in early mortality of metastatic melanoma patients: A SEER-based analysis (2000–2021)
Faizan Ahmed, Aman Ullah, Abdullah Zia, Umar Iqbal, Tehmasp Mirza, Najam Gohar, Omar Kamel, Izzah Nayyab, Sherif Eltawansy, Ammara Fayyaz, Yasir Rashid, Mohamed Bakr, Mohammad Hossain, Kainat Aman
Hematologic and systemic complications of bispecific antibodies: Insights from a National Inpatient Study
Najam Gohar, Faizan Ahmed, Izzah Nayyab, Abdullah Zia, Tehmasp Mirza, Umar Iqbal, Mohammad Hossain, Kainat Aman, Grishma Sharma, Aman Ullah, Yusra Junaid, Sherif Eltawansy, Mohamed Bakr, Hira Zahid
Real-world outcomes and toxicity profiles of bispecific antibodies: A nationwide multiyear study
Faizan Ahmed, Najam Gohar, Aman Ullah, Abdullah Zia, Izzah Nayyab, Tehmasp Mirza, Umar Iqbal, Mohammad Hossain, Kainat Aman, Grishma Sharma, Yusra Junaid, Sherif Eltawansy, Mohamed Bakr, Hira Zahid
Incidence and survival trends in adolescents and young adults with carcinoma of unknown primary: Insights from the SEER database (2000–2021)
Omar Kamel, Faizan Ahmed, Aman Ullah, Umar Iqbal, Tehmasp Mirza, Abdullah Zia, Najam Gohar, Sherif Eltawansy, Mohammad Hossain, Izzah Nayyab, Mohamed Bakr, Husnain Ahmad, Kainat Aman, Maryam Nasir, Ammara Fayyaz
Assessing the contribution of metabolic risk factors to uterine cancer-related deaths and predictions until 2030 and 2050
Shree Rath, Muzamil Khan, Nouman Aziz, Waseem Nabi, Adnan Bhat
Mortality rate disparities in breast cancer with obesity: Insights from CDC WONDER analysis of two decades
Maria Qadri, Shafiq Rahman, Muhammad Ibrahim, Fatima Ashfaq, Haris Mumtaz Malik, Adnan Bhat, Waseem Nabi
Atezolizumab plus bevacizumab in combination with platinum based chemotherapy for ovarian cancer: A systematic review and meta-analysis of randomized control trials
Maria Qadri, Shafiq Rahman, Muhammad Nabeel Saddique, Muhammad Ibrahim, Muhammad Rehman, Zaid Khan, Haris Mumtaz Malik, Adnan Bhat, Waseem Nabi
Assessing global trends of cervical cancer: 1990-2021
Victor Ghosh, Shree Rath, Amar Lal, Muzamil Khan, Nouman Aziz, Waseem Nabi, Adnan Bhat
Extended vs standard lymphadenectomy in patients of pancreatic head adenocarcinoma undergoing pancreatoduodenectomy: A systematic review and updated meta-analysis
Haadi Ur Rehman, Haris Mumtaz Malik, Amna Idrees, Muhammad Saaim Saleem, Beenish Sabir, Javed Iqbal, Afifa Kulsoom, Faraz Hassan Ali, Adnan Bhat, Waseem Nabi, Allahdad Khan, Muhammad Ibrahim, Maria Qadri
Analyzing trends in vulvovaginal cancer mortality in the United States from 1999 to 2020
Ahdia Noor, Muzamil Khan, Fatima Shahid, Shree Rath, Nouman Aziz, Waseem Nabi, Adnan Bhat, Belal Hamed, Ahmad Basharat, Maryam Inam Zaroo
Efficacy and safety of oral tazemetostat, an EZH2 inhibitor, in relapsed or refractory B-cell non-Hodgkin lymphomas: A systematic review and proportionality meta-analysis
Haris Mumtaz Malik, Beenish Sabir, Shahroz Ansar, Shazia Hashim, Adnan Bhat, Javed Iqbal, Allahdad Khan, Muhammad Ibrahim, Maria Qadri, Noor Saleem, Shamikha Cheema, Muhammad Riyyan
Burden of pediatric CNS malignancies across 204 countries from 1990 to 2021
Muzamil Khan, Waseem Nabi, Nouman Aziz, Shree Rath, Adnan Bhat, Mir Wajid Majeed, Mir Shahnawaz, Maryam Inam Zaroo, Mishaim Khan
Busulfan and cyclophosphamide vs busulfan and fludarabine for myeloablation in the patients of acute myeloid leukaemia/ myelodysplastic syndrome undergoing stem cell transplant: A systematic review and meta-analysis
Haris Mumtaz Malik, Ramzan Hassan Farooq, Faraz Hassan Ali, Beenish Sabir, Fatima Faraz, Adnan Bhat, Nouman Aziz, Waseem Nabi, Allahdad Khan, Javed Iqbal, Muhammad Ibrahim, Maqsood Mehboob Khan, Maria Qadri
Trends in mortality due to CNS neoplasms in the US from 1999 to 2020
Muhammad Riyyan, Muzamil Khan, Amar Lal, Muhammad Asjad Saleem, Belal Hamed, Nouman Aziz, Waseem Nabi, Adnan Bhat, Shree Rath
Mortality trends in multiple myeloma and cardiovascular disease in the US (1999–2020)
Kainat Aman, Faizan Ahmed, Aman Ullah, Najam Gohar, Abdullah Zia, Yusra Junaid, Hira Zahid, Areehah Zafar Masood, Omar Kamel, Mohammad Hossain, Sherif Eltawansy, Mohamed Bakr, Adnan Bhat
Analyzing trends and disparities in polycythemia vera mortality in the U.S. from 1999 to 2020
Muhammad Asjad Saleem, Muzamil Khan, Amar Lal, Shree Rath, Belal Hamed, Madona Pakkam, Nouman Aziz, Waseem Nabi, Adnan Bhat
Cervical cancer mortality trends and disparities in women of the United States: A two-decade retrospective analysis
Hassan Ijaz, Shafiq Rahman, Shamikha Cheema, Pakeeza Saif, Muhammad Haris Khan, Umaima Cheema, Shariq Ahmad Wani, Waseem Nabi, Nouman Aziz, Roshan Afshan, Adnan Bhat, Kamran Habib, Falah Fayaz
Obesity-related cancer mortality in the US (1999–2020): A CDC WONDER analysis
Kainat Aman, Abdullah Zia, Aman Ullah, Faizan Ahmed, Najam Gohar, Izzah Nayyab, Tehmasp Mirza, Mohammad Hossain, Yusra Junaid, Sherif Eltawansy, Mohamed Bakr, Hira Zahid, Adnan Bhat, Abdul Waheed
Comparative safety and efficacy of tislelizumab with or without chemotherapy versus chemotherapy alone in patients with lung cancer: A systematic review and meta-analysis
Aman Ullah, Faseeh Haider, Adnan Bhat, Vatsal Makhija, Saloni Srivastava, Haris Mumtaz Malik, Mohammed Dheyaa Marsool, Fatima Binte Athar, Faizan Ahmed, Ajay Kumar, Waseem Nabi, Nouman Aziz, Muzamil Khan, Shariq Ahmad Wani, Moazzam Shahzad
Alcohol use and liver cancer mortality in the U.S. (1999–2020): A CDC WONDER analysis
Izzah Nayyab, Najam Gohar, Faizan Ahmed, Tehmasp Mirza, Abdullah Zia, Aman Ullah, Sherif Eltawansy, Yusra Junaid, Mohamed Bakr, Ammara Fayyaz, Yasir Rashid, Hira Zahid, Kainat Aman, Mohammad Hossain, Areehah Zafar Masood, Mian Zahid Jan Kakakhel, Omar Kamel, Adnan Bhat, Faseeh Haider
Efficacy and safety of immune checkpoint inhibitors in patients with unresectable metastatic colon cancer with microsatellite instability high or mismatch repair deficiency: A systematic review and meta-analysis
Shariq Ahmad Wani, Allahdad Khan, Kamran Habib, Haris Mumtaz Malik, Waseem Nabi, Nouman Aziz, Mir Wajid Majeed, Adnan Bhat, Aisha Reshie, Oufaq Zehra, Syed Saqib Balkhi, Syed Bazilah Rufai, Noma Nazir, Novfa Iftikhar, Falah Fayaz, Faisal Rashid, Shamikha Cheema, Muzamil Khan
Prognostic significance of metaplasia in adenocarcinoma of the lung: A National Cancer Database analysis
Sukhrob Makhkamov, Nouman Aziz, Waseem Nabi, Mst. Khaleda Khatun, Muzamil Khan, Shree Rath, Ahmad Basharat, Mir Shahnawaz, Adnan Bhat, Dimitri Chepkunov, Daye Chung, Yasmine Elsherif, Ali Usama, Muhammad Mudassar, Anees Cheema, Haseeb Tareen, Rana Uzair Ahmad, Sonu Sahni, Nelli Fromer
Survival outcomes in early-stage cutaneous desmoplastic melanoma: A National Cancer Database analysis
Erika LaBelle, Nouman Aziz, Waseem Nabi, Muzamil Khan, Adnan Bhat, Mehwish Zia, Ahmad Basharat, Shree Rath, Muhammad Mudassar, Manas Pustake, Sukhrob Makhkamov, Rohan Garje, Mohammad Arfat Ganiyani, Mir Shahnawaz, Samreen Aziz, Ayesha Aziz, Anees Cheema, Dipesh Rohita, Usama Ali, Nelli Fromer
Comparative survival outcomes among histological subtypes of pulmonary adenocarcinoma: A nationwide study
Nouman Aziz, Waseem Nabi, Muzamil Khan, Sukhrob Makhkamov, Anees Cheema, Nadia Akbar, Ali Usama, Ahmad Basharat, Erika LaBelle, Haseeb Tareen, Adnan Bhat, Mir Wajid Majeed, Muhammad Mudassar, Rana Uzair Ahmad, Muhammad Jawad Javed, Junaid Anwar, Usman Ilyas, Muhammad Salman Faisal, Moazzam Shahzad
Predictors of survival in advanced-stage, high grade primary peritoneal serous cystadenocarcinoma: An NCDB based analysis
Haseeb Tareen, Nouman Aziz, Waseem Nabi, Muzamil Khan, Mohammad Arfat Ganiyani, Dipesh Rohita, Rohan Garje, Ahmad Basharat, Ali Usama, Anees Cheema, Shree Rath, Mir Wajid Majeed, Adnan Bhat, Yasmine Elsherif, Sukhrob Makhkamov, Adnan Ali, Jazayeri Babak, Juan Fuentes-Rosales, Jennifer Gulas, Nelli Fromer
Comparative survival outcomes among histological subtypes of non-small cell lung cancer in the United States
Waseem Nabi, Nouman Aziz, Mst. Khaleda Khatun, Sukhrob Makhkamov, Shree Rath, Ahmad Basharat, Mohammad Arfat Ganiyani, Rohan Garje, Anees Cheema, Ali Usama, Mir Wajid Majeed, Shariq Ahmad Wani, Adnan Bhat, Muzamil Khan, Muhammad Jawad Javed, Junaid Anwar, Zeyar Thet, Wehbeh Wehbeh, Mir Shahnawaz, Nelli Fromer
